In patients with diabetes mellitus and coronary artery disease undergoing PCI , paclitaxel-eluting stents were not shown to be noninferior to everolimus-eluting stents , and they resulted in higher rates of target-vessel failure , myocardial infarction , stent thrombosis , and target-vessel revascularization at 1 year .